Evotec SE (EVO) Enterprise Value (2009 - 2026)
Evotec SE (EVO) reported Enterprise Value of -$520704.3 for Q1 2026, down 33.27% on a YoY basis from -$780310.2 in Q1 2025, and down 667.39% sequentially from -$67853.9 in Q4 2025.
Evotec SE (EVO) Enterprise Value (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 10 years of Enterprise Value data on file, last reported at -$520704.3 in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 33.27% year-over-year to -$520704.3; the trailing twelve-month figure through Mar 2026 stood at -$520704.3 (down 33.27% YoY), and the FY2025 full-year result was -$67853.9, up 99.98% from the prior year.
- Enterprise Value slipped to -$520704.3 in Q1 2026, from -$67853.9 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$67853.9 in Q4 2025 to a low of -$465.3 billion in Q1 2024.
- A 5-year average of -$55.5 billion and a median of -$947417.2 in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 7151845.65% in 2022 and jumped 100.0% in 2025, its largest moves.
- Tracing EVO's Enterprise Value over 5 years: stood at -$733.0 million in 2022, then increased by 11.33% to -$650.0 million in 2023, then surged by 48.92% to -$332.0 million in 2024, then jumped by 99.98% to -$67853.9 in 2025, then plunged by 667.39% to -$520704.3 in 2026.
- Business Quant data shows EVO's Enterprise Value at -$520704.3 in Q1 2026, -$67853.9 in Q4 2025, and -$277379.4 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | -520,704.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -520,704.35 |
| Dec 31, 2025 | -67,853.86 |
| Sep 30, 2025 | -277,379.36 |
| Jun 30, 2025 | -393,923.10 |
| Mar 31, 2025 | -390,715.11 |
| Dec 31, 2024 | -331.99 Mn |
| Sep 30, 2024 | -254.02 Bn |
| Mar 31, 2024 | -465.30 Bn |
| Dec 31, 2023 | -649.99 Mn |
| Dec 31, 2022 | -733.04 Mn |
| Sep 30, 2022 | -830,483.30 |
| Jun 30, 2022 | -947,417.23 |
| Mar 31, 2022 | -959,392.24 |
| Dec 31, 2021 | -800.31 Mn |
| Sep 30, 2021 | -393.18 Bn |
| Jun 30, 2021 | -13.25 |
| Dec 31, 2020 | -516.60 Mn |
| Sep 30, 2020 | -79.43 |
| Dec 31, 2019 | -306.65 Mn |
| Sep 30, 2010 | -24.27 Bn |